tavaborole: Clinical Trials

5 trials of tavaborole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5

Follow tavaborole: new trials by email Literature Review of tavaborole trials Research Report on tavaborole

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
AN2690 - Onychomycosis
Phase 2CompletedPfizer202007-03-312018-02-20
Study of Different Doses of a Novel Treatment for Onychomycosis
AN2690, 2.5%, AN2690, 5%, AN2690, 7.5% - Distal, Subungual Onychomycosis
Phase 2CompletedPfizer282006-06-302018-02-20
Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis
AN2690 - Onychomycosis
Phase 2CompletedPfizer602006-06-302018-02-20
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
AN2690 - Onychomycosis
Phase 2CompletedPfizer152006-04-302019-02-21
Study of Different Doses of a Novel Treatment for Onychomycosis
AN2690, 2.5%, AN2690, 5%, AN2690, 7.5% - Distal, Subungual Onychomycosis
Phase 2CompletedPfizer1592006-02-282018-12-12

Conditions studied

Onychomycosis (5)

Sponsors

Pfizer (5)

Countries

United States (4)  ·  Mexico (1)